Moderna Inc. shares are selling off Wednesday, after the Trump administration took aim at the science behind the ...

As Moderna has significantly lagged behind the broader market over the past year, Wall Street analysts maintain a cautious ...

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary ...

Reports second quarter revenues of $0.1 billion, GAAP net loss of $(0.8) billion and GAAP EPS of $(2.13) Updates 2025 ...

If Canada is serious about becoming a global powerhouse in fields such as AI and life sciences then this intrapreneur mindset ...

Currently trading with a volume of 3,803,131, the MRNA's price is down by -1.06%, now at $27.18. RSI readings suggest the stock is currently is currently neutral between overbought and oversold.

Research that helped develop mRNA vaccines won the Nobel Prize in Physiology or Medicine in 2023. Members of the scientific community are criticizing Kennedy for his decision.

A tremendous step backward, the politicization of science, and RFK Jr., who has been a lifelong anti-vaccine propagandist and ...

This was one in a continuing line of moves that has put RFK Jr.'s vaccine skepticism into public policy, though scientists ...

The targeting of the vaccine technology once considered revolutionary follows intense criticism by conservatives and ...

One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step ...

The Health and Human Services secretary cancelled nearly $500 million in contracts related to the development of future ...